ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

08 أغسطس 2025 06:45:08 بحسب NetDania Notify

Ascendis Pharma Reports Second Quarter 2025 Financial Results

07 أغسطس 2025 13:01:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

07 أغسطس 2025 11:00:18 بحسب NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

05 أغسطس 2025 06:45:04 بحسب NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

04 أغسطس 2025 13:05:18 بحسب NetDania Notify

Ascendis Pharma to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025

31 يوليو 2025 13:01:00 بحسب Nasdaq GlobeNewswire

FDA Approves SKYTROFA® (Lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Adults with Growth Hormone Deficiency

28 يوليو 2025 04:00:00 بحسب Nasdaq GlobeNewswire

New 3-Year Phase 3 Data Confirmed Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism, Including Improvements in Biochemistries, Kidney Function, and Quality of Life

14 يوليو 2025 13:01:00 بحسب Nasdaq GlobeNewswire

Ascendis to Share Its Latest Endocrinology Rare Disease Data at ENDO 2025

07 يوليو 2025 13:01:00 بحسب Nasdaq GlobeNewswire

TransCon® hGH Boosted Treatment Benefits of TransCon® CNP in Children with Achondroplasia at Week 26 Interim Analysis of the Phase 2 COACH Trial

09 يونيو 2025 04:00:00 بحسب Nasdaq GlobeNewswire

FDA Accepts TransCon® CNP NDA for Priority Review

02 يونيو 2025 05:00:00 بحسب Nasdaq GlobeNewswire

New Data Shows Improvements in Growth and Bone Morphometry in Children with Achondroplasia Treated with TransCon® CNP (Navepegritide)

13 مايو 2025 13:01:00 بحسب Nasdaq GlobeNewswire

New 4-Year Data Shows Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism

12 مايو 2025 13:45:30 بحسب Nasdaq GlobeNewswire

Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE & ESE 2025

05 مايو 2025 05:30:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

02 مايو 2025 06:45:50 بحسب NetDania Notify

Ascendis Pharma Reports First Quarter 2025 Financial Results

01 مايو 2025 13:01:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

01 مايو 2025 06:45:35 بحسب NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

30 أبريل 2025 10:59:46 بحسب NetDania Notify

Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025

24 أبريل 2025 13:01:00 بحسب Nasdaq GlobeNewswire

Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia

31 مارس 2025 13:01:00 بحسب Nasdaq GlobeNewswire